Cargando…
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
BACKGROUND: A deregulated energy metabolism is a hallmark of malignant disease that offers possible future targets for treatment. We investigated the prognostic value of the glycolytic enzymes glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and pyruvate kinase type M2 (PKM2), mitochondrial β-F1-ATP...
Autores principales: | Hjerpe, Elisabet, Egyhazi Brage, Suzanne, Carlson, Joseph, Frostvik Stolt, Marianne, Schedvins, Kjell, Johansson, Hemming, Shoshan, Maria, Åvall-Lundqvist, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874631/ https://www.ncbi.nlm.nih.gov/pubmed/24252137 http://dx.doi.org/10.1186/1472-6890-13-30 |
Ejemplares similares
-
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
por: Falkenius, Johan, et al.
Publicado: (2017) -
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
por: Wintzell, My, et al.
Publicado: (2012) -
Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance
por: Azimi, A, et al.
Publicado: (2014) -
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
por: Azimi, Alireza, et al.
Publicado: (2017) -
Can BCS and BEC be synthetized?
por: Aguilera-Navarro, V C, et al.
Publicado: (1997)